Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer
Clinical trial NCT06455046 · UNKNOWN
Trial details
- NCT number
- NCT06455046
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-11
- Primary completion
- 2025-10-10
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.